Research Analysts’ updated eps estimates for Monday, October 12th:
Aardvark Therapeutics (NASDAQ:AARD) had its neutral rating reiterated by analysts at BTIG Research.
Absci (NASDAQ:ABSI) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $16.00 target price on the stock.
Compugen (NASDAQ:CGEN) had its buy rating reissued by analysts at HC Wainwright. They currently have a $4.00 target price on the stock.
Endava (NYSE:DAVA) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $5.00 price target on the stock.
Entain (LON:ENT) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. They currently have a GBX 1,000 target price on the stock.
Alphabet (NASDAQ:GOOGL) had its overweight rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $420.00 target price on the stock.
Hays (LON:HAS) had its underperform rating reaffirmed by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 45 price target on the stock.
Harmony Biosciences (NASDAQ:HRMY) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $50.00 price target on the stock.
hVIVO (LON:HVO) had its buy rating reissued by analysts at Peel Hunt. Peel Hunt currently has a GBX 14 price target on the stock.
Insmed (NASDAQ:INSM) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $220.00 price target on the stock.
ITM Power (LON:ITM) had its buy rating reissued by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 200 target price on the stock.
Kimball Electronics (NASDAQ:KE) had its overweight rating reiterated by analysts at Cantor Fitzgerald.
Eli Lilly and Company (NYSE:LLY) had its outperform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $1,500.00 target price on the stock.
Mineralys Therapeutics (NASDAQ:MLYS) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $56.00 target price on the stock.
Motorpoint Group (LON:MOTR) had its buy rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a GBX 170 target price on the stock.
ServiceNow (NYSE:NOW) had its buy rating reissued by analysts at BTIG Research. BTIG Research currently has a $170.00 price target on the stock.
Vaxcyte (NASDAQ:PCVX) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $120.00 target price on the stock.
Polar Capital (LON:POLR) had its buy rating reaffirmed by analysts at Peel Hunt. The firm currently has a GBX 1,200 price target on the stock.
Protagonist Therapeutics (NASDAQ:PTGX) had its outperform rating reissued by analysts at Leerink Partners. The firm currently has a $190.00 price target on the stock, up from their previous price target of $150.00.
Standard Motor Products (NYSE:SMP) had its buy rating reissued by analysts at Roth Capital. They currently have a $54.00 price target on the stock.
Snowflake (NYSE:SNOW) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $450.00 target price on the stock.
SOPHiA GENETICS (NASDAQ:SOPH) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $14.00 target price on the stock.
Sirius Real Estate (LON:SRE) had its buy rating reissued by analysts at Peel Hunt. Peel Hunt currently has a GBX 125 price target on the stock.
Syncona (LON:SYNC) had its buy rating reiterated by analysts at Peel Hunt. They currently have a GBX 189 price target on the stock.
LON:TIN (LON:TIN) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 153 target price on the stock.
Uber Technologies (NYSE:UBER) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $90.00 target price on the stock.
Unilever (LON:ULVR) had its hold rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 5,150 price target on the stock.
VP (LON:VP) had its buy rating reiterated by analysts at Peel Hunt. They currently have a GBX 550 target price on the stock.
Water Intelligence (LON:WATR) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 515 target price on the stock.
Receive News & Ratings for Aardvark Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aardvark Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.
